Description of Event or Problem · 1
PT RECEIVED A KIDNEY TRANSPLANT ON (B)(6) 2016 THAT WAS PRESENTED IN SPS SOLUTION. PT ENDED UP WITH A FUNGAL INFECTION THAT RESULTED IN LOSING THE TRANSPLANTED KIDNEY. REPORTS TO THIS FACILITY STATED THAT THE SPS SOLUTION WAS CONTAMINATED: "BRIEF SUMMARY OF REPORT: CDC, HRSA, AND FDA ARE INVESTIGATING BACTERIAL CONTAMINATION OF SPS-1, AN ORGAN PRESERVATION SOLUTION DISTRIBUTED BY ORGAN RECOVERY SYSTEMS (ORS). DESCRIPTION: THIS IS AN UPDATE TO AN EPI-X POSTED ON (B)(6) 2017, WHICH REPORTED POTENTIAL BACTERIAL CONTAMINATION IN SPS-1 LOTS PBR-0074-337, PBR-0060-386, PBR-0074-330, AND PBR-0060-392. FDA'S INVESTIGATION OF POTENTIAL CONTAMINATION OF SEVERAL LOTS OF SPS-1, MANUFACTURED BY ORGAN RECOVERY SYSTEMS (ORS) IS ONGOING. WE RECOMMEND THAT ORGAN PROCUREMENT ORGANIZATIONS (OPO) AND TRANSPLANT FACILITIES SHOULD CONSIDER TRANSITIONING TO ALTERNATE, FDA-CLEARED ORGAN PRESERVATION FLUID PRODUCTS FROM OTHER MFRS."